During 1970-87 43 patients with unexplained pulmonary hypertension (mean pulmonary arterial pressure > 25 mm Hg) were admitted to the Brompton Hospital and classified by angiographic criteria as having either symmetrical peripheral pulmonary artery pruning (thought to represent primary plexogenic pulmonary arteriopathy), n = 21, or asymmetrical pulmonary arterial occlusions (thought to represent chronic thromboembolic disease), n = 22. Patients with symmetrical pulmonary arteriopathy had significantly higher mean pulmonary arterial pressures (67 mm Hg) at the time of presentation than those with asymmetrical pulmonary arteriopathy (49 mm Hg). Clinical distinction between these two groups was impossible. Survival from the time of diagnosis was similarly poor in the two groups (26 weeks and 38 weeks) and did not correlate with any of the haemodynamic measurements. The difficulties in making distinctions between these conditions are discussed.
Chronic pulmonary hypertension may be due to various cardiac or pulmonary conditions,' the causes of which are often apparent clinically or as a result of investigations. "Primary" pulmonary hypertension is a term that has often been used synonymously with "clinically unexplained pulmonary hypertension," and this confusing terminology2 has to some extent persisted despite attempts by the World Health Organisation to be more specific by subdividing unexplained pulmonary hypertension into three pathological categories3: (1) primary plexogenic pulmonary arteriopathy; (2) recurrent thromboembolic pulmonary hypertension; and (3) pulmonary veno-occlusive disease. The last, being extremely rare, is excluded from our series and will not be discussed further. Clinically it is impossible to distinguish these conditions,4 though a clear history of prior repeated episodes of deep venous thrombosis or pulmonary embolism suggests a thromboembolic cause in a few cases. 5 
Results

THE PATIENTS
The mean age at presentation of the 21 patients with symmetrical pulmonary arteriopathy (five male, 16 female) was 39 (range 9-62) years and that of the 22 patients with asymmetrical pulmonary arteriopathy (nine male, 13 female) was 46 (range 15-68) years. Although patients with symmetrical pulmonary arteriopathy were younger and more likely to be female these differences were not significant. One woman with asymmetrical and two with symmetrical pulmonary arteriopathy had taken the contraceptive pill within two years of diagnosis and two in each group had been pregnant during this period. No patient was prescribed the contraceptive pill or became pregnant after diagnosis.
Of the patients with symmetrical pulmonary arteriopathy, two were current smokers, one was taking fenfluramine at the time of diagnosis, one had Raynaud's disease, and two had mothers who died of unknown causes when relatively young (38 and 40 years). Of those diagnosed as having asymmetrical pulmonary arteriopathy, three were current smokers, one had a clinical diagnosis of mild rheumatoid arthritis, and one had a mother who had died after a pulmonary embolism. No other relevant factors emerged from direct questioning. Presentation in childhood was unusual in both groups. SYMPTOMS (table 1) Symptoms were similar in the two groups. All patients had exertional dyspnoea and reduced exercise tolerance. Pleuritic chest pain and haemoptyses occurred at some stage during the presenting illness more frequently in those with asymmetrical (five, 23%) than sym- Examples of the difficulty in classifying patients when alive correctly are provided by two studies. In one of these a large group of patients diagnosed clinically and angiographically as having primary plexogenic pulmonary hypertension were reviewed and those with any evidence of pulmonary embolism or deep venous thrombosis were excluded. Despite this exclusion, in over half of the necropsies performed plexogenic lesions were absent and thrombus was the major histological abnormality. ' 4 We do not intend to imply that such problems with histological analysis invalidate its use in distinguishing these conditions. Histology is probably still the most accurate means of assessing the nature of pulmonary vascular disease; but the area of overlap, where histological appearances may be difficult to interpret, raises the possibility that there may be a spectrum of disease rather than two well defined conditions.
The argument for using angiography to classify patients with unexplained pulmonary hypertension is that it is probably less hazardous than lung biopsy and is able to show vessels of sufficient size from the whole of both lungs, especially when magnified views are used,4 rather than the inevitably small areas available from biopsy samples. The same argument favours radionuclide perfusion lung scanning: scans have been shown to be normal in primary plexogenic pulmonary arteriopathy'6 but may be abnormal in chronic thromboembolic disease,4 13 especially in patients with unresolved emboli affecting large rather than small pulmonary arteries.'7 These patients must be identified because some may be suitable for pulmonary thrombectomy and endarterectomy,18 especially those who have adequate-' distal pulmonary perfusion via collateral vessels shown by bronchial arteriography. 9 There is clearly little point in classifying patients angiographically unless such a classification either correlates well with lung biopsy appearances (which we have not had the data to assess) or defines groups ofpatients with '3 In our series the available pulmonary arteriograms were reviewed blindly by one of us (IHK) and the results found to be 100% concordant with the previous reports, showing that the angiographic criteria were at least consistent. Whether these criteria, any more than histological ones, truly identify two distinct diseases remains uncertain.
We and others415 have been unable to identify any clinical features that distinguish between these two angiographic groups of patients, though some trends were noted in our results. Patients with symmetrical pulmonary arteriography were more likely to be female and those with asymmetrical disease were older and had less severe pulmonary hypertension at the time of presentation and appeared to live longer; The duration of symptoms before diagnosis in both groups was positively correlated with length of survival. Although some have shown a relation between survival and haemodynamic measurements at presentation,24 none of our haemodynamic data showed any correlation with survival. To our knowledge only one group of workers has classified patients with idiopathic pulmonary hypertension on angiographic grounds and compared the clinical features of the two groups, and their results were similar to ours. 
